Licensing deal paves way for wider trial of OMRF Glioblastoma therapeutic
113 views · Published 27 December 2018 · 2:58 · Indexed 22 October 2026
Channel: The Oklahoman · 2018 · News & Politics
Licensing of an investigational drug called OKN-007 developed by the Oklahoma Medical Research Foundation (OMRF) by a company focused on development and commercialization of biopharmaceutical drugs has brought hope to glioblastoma patients.
More from this channel
-
2:37
Thunder Girls - Last Practice Before Season
-
5:38
Food Dude - Chili
-
3:04
OKC officer pulls man over for anti-Obama sign on vehicle
-
3:20
Obama sign causes sign
-
0:31
The Oklahoman's iPad App Commercial
-
2:07
Director of events and entertainment for Oklahoma City Thunder interviewed
-
5:38
Static Ep 59- Gentle Chrome
-
24:08
Google Hangout: The Big 12's apology